Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,746,778
+$15,217,895 QoQ
Shares Held
319,595
+484.9% QoQ
Ownership
0.191%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#70
of 424 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Derivatives in ALKS
reported options exposure · as of Jun 30, 2026CallValue
$1,310,000
CallShares
25,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $1,140,219,030 across 49 Drug Manufacturers - Specialty & Generic names. ALKS ranks #14 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
409,074 | $221,648,565 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
3,853,212 | $179,212,890 | |
| 3 | ZTS |
Zoetis Inc.
|
1,813,759 | $130,336,721 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,265,321 | $110,629,075 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,098,945 | $86,119,713 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
2,725,889 | $67,084,128 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
507,207 | $41,986,595 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
336,399 | $37,320,105 |
All Filings in ALKS
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,746,778 | 319,595 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $1,310,000 | 25,000 | Call | Sole | 2026-08-14 | |
| 2025-12-31 | $1,528,883 | 54,642 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,423,800 | 147,460 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,229,834 | 77,939 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,848,007 | 177,105 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $18,420,952 | 640,506 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $2,876,000 | 100,000 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $23,073,612 | 824,352 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $7,647,275 | 282,500 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $17,885,825 | 660,725 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,556,931 | 236,371 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,400,500 | 50,000 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $40,544,503 | 1,447,501 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $51,927,670 | 1,659,031 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $70,997,022 | 2,518,518 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $89,570,635 | 3,427,885 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $28,895,198 | 1,294,008 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $19,981,344 | 670,740 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,949,927 | 226,147 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $7,598,623 | 326,682 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $914,776 | 29,662 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $18,575,542 | 757,567 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $15,069,305 | 806,708 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,882,536 | 294,864 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $19,433,777 | 1,001,225 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $27,188,073 | 1,885,442 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||